Chronic Hepatitis B Virus
Research results from University of Southampton update understanding of chronic hepatitis B virus
Published in Hepatitis Weekly, February 8th, 2010
According to recent research from Southampton, the United Kingdom, "This paper presents a summary of the evidence review group (ERG) report into the clinical and cost-effectiveness of entecavir for the treatment of chronic hepatitis B (CHB) in adults based upon a review of the manufacturer's submission to the National Institute for Health and Clinical Excellence (NICE) as part of the single technology appraisal (STA) process. The submission's evidence came from five randomised controlled trials (RCTs), of good methodological quality and measuring a range of clinically relevant outcomes, comparing entecavir with lamivudine."
"After I year of treatment entecavir was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-02-08)
More Articles from Hepatitis Weekly
- Wiley-Blackwell
Non-alcoholic fatty liver disease associated with high mortality rates - Chronic Hepatitis C Virus
New chronic hepatitis C virus study findings reported from San Paolo Hospital - Hepatitis C Virus
Findings from Y. Yoshida and co-authors provide new insights into hepatitis C virus - Hepatitis C Virus
New hepatitis C virus research from F. Maltais and co-researchers described - Hepatitis C Virus
New hepatitis C virus research from R. Two et al outlined - Hepatitis C Virus
New hepatitis C virus research from T.M. Chen et al outlined - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
